doi: 10.1136/bmj.c869 Summary Keywords obesity, GLP-1, GLP-1 receptor analog, exenatide, pediatrics, glycemic control, GLP-1 receptor agonist, treatment Citation Stenlid R, Cerenius SY, Wen Q, Aydin BK, Manell H, Chowdhury A, Kristinsson H, Ciba I, Gjessing ES, Mrwald K, Gomahr J, Heu V, Weghuber D, Forslund A and Bergsten P (2023) Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control
Omega-3 Fatty Acids: The Brain's Structural Integrity Did you know your brain is nearly 60% fat
Sokolov O, Kost N, Andreeva O, Korneeva E, Meshavkin V, Tarakanova Y, Zozulya A (2014) Autistic children display elevated urine levels of bovine casomorphin-7 immunoreactivity
McDermott, J